3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Malignant Solid Neoplasm
1
Kidney Neoplasms
1
Hematopoietic and Lymphatic System Neoplasm
1
HIV Infections
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Cigarette Smoking-Related Carcinoma
1
Carcinoma, Renal Cell
1
Interventions
Specimen Handling
3
Biopsy
3
X-Rays
2
Standard of Care
2
Practice Guidelines as Topic
2
Interviews as Topic
2
trastuzumab biosimilar HLX02
1
pertuzumab
1
erdafitinib
1
copanlisib
1
Trastuzumab
1
Palliative Care
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Methods
1
Magnetic Resonance Spectroscopy
1
Health Promotion
1
Educational Status
1
Early Intervention, Educational
1
CT-P6
1
2C4 antibody
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Malignant Solid Neoplasm
×
Health Promotion
×
30 days
×
Clear all
NCT06541158
2026-05-28
TRACT
Emory University
Phase NA
Recruiting
76 enrolled